# Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)

> **NCT06630104** · NA · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 82 (estimated)

## Conditions studied

- Lymphoproliferative Disorder
- Multiple Myeloma

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Aspiration
- **OTHER:** Electronic Health Record Review
- **PROCEDURE:** Follow-Up
- **OTHER:** Genetic Counseling
- **OTHER:** Genetic Testing

## Key facts

- **NCT ID:** NCT06630104
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-22
- **Primary completion:** 2027-12-16
- **Final completion:** 2027-12-16
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2026-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06630104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06630104, "Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06630104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*